Demirkiran F, Arvas M, Erkun E, Kosebay D, Isiloglu H, Aktas E, Mil Z
Department of Obstetrics & Gynecology, Cerrhpasa Medical Faculty, University of Istanbul, Turkey.
Eur J Gynaecol Oncol. 1995;16(5):403-9.
In patients with endometrial cancer, preoperative identification of certain poor prognostic factors is helpful in planning therapy. To determine the place of cervico-vaginal cytology in this respect, we have studied the relationship between cervico-vaginal cytology and the well-known prognostic factors of endometrial cancer such as grade, myometrial invasion, peritoneal cytology, stage and histological subtype. A hundred and sixty two patients, all of whom underwent surgical therapy in our clinic, were included in this study in order to correlate the cytological results with the pathological findings. Cervico-vaginal cytology was negative in 88 patients (54%), suspicious in 26 patients (16%) and malignant in 48 patients (30%). Twenty four per cent of cases with adenocarcinoma and adenoachantoma, and fifty two per cent of patients with adenosquamous carcinoma, papillary adenocarcinoma and clear cell carcinoma had positive cervicovaginal cytology (p < 0.001). Seventy four per cent of patients with negative cervico-vaginal cytology had grade I tumor, while 5% of patients with negative cytology had grade III tumor. On the other hand, only 9% of patients with positive cervico-vaginal cytology had grade I tumor, while 55% had grade III tumor (p < 0.001). 8% of patients with inner 1/2 myometrial invasion had positive cytology, whereas 51% of patients with 1/2 outer myometrial invasion had malignant cells in their smear (p < 0.001). As for the staging of the endometrial cancer according to FIGO, 19% of patients with Stage I disease had positive cervico-vaginal cytology while 60% of patients in Stage II and 66% of patients in Stage III-IV had positive cytology (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
对于子宫内膜癌患者,术前识别某些不良预后因素有助于制定治疗方案。为了确定宫颈阴道细胞学检查在这方面的作用,我们研究了宫颈阴道细胞学检查与子宫内膜癌一些已知预后因素之间的关系,这些因素包括分级、肌层浸润、腹腔细胞学检查、分期和组织学亚型。本研究纳入了162例均在我院接受手术治疗的患者,以便将细胞学检查结果与病理结果进行关联。88例患者(54%)的宫颈阴道细胞学检查结果为阴性,26例患者(16%)为可疑,48例患者(30%)为恶性。腺癌和腺棘皮瘤患者中有24%、腺鳞癌、乳头状腺癌和透明细胞癌患者中有52%的宫颈阴道细胞学检查呈阳性(p<0.001)。宫颈阴道细胞学检查结果为阴性的患者中,74%患有I级肿瘤,而细胞学检查结果为阴性的患者中只有5%患有III级肿瘤。另一方面,宫颈阴道细胞学检查结果为阳性的患者中只有9%患有I级肿瘤,而55%患有III级肿瘤(p<0.001)。肌层内1/2浸润的患者中有8%细胞学检查呈阳性,而肌层外1/2浸润的患者中有51%涂片中有恶性细胞(p<0.001)。根据国际妇产科联盟(FIGO)对子宫内膜癌的分期,I期患者中有19%的宫颈阴道细胞学检查呈阳性,而II期患者中有60%、III-IV期患者中有66%的细胞学检查呈阳性(p<0.05)。(摘要截断于250字)